- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05127733
Online Cognitive Behavioural Therapy for Substance Use Disorder: The Impact of Peer Support
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M6J 1H1
- Campbell Family Mental Health Research Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years of age and above
- Fluency in English
- Understanding and willingness to comply with study requirements & provide informed consent
- Current substance use disorder
- Have used alcohol or substances within the past 30 days
- Registration with CAMH Addictions Program outpatient services
Exclusion Criteria:
- Current psychosis or mania
- Current psychiatric disorder requiring care more urgently than substance use, including acute intoxication or withdrawal requiring medical attention
- Significant neurological disorder or physical illness likely to interfere with participants
- Any known practical factors that would preclude participation (e.g., extended absences)
- Inability to read at a sixth grade level
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Online Cogntivie Behavioural Therapy
Breaking Free Online (BFO) is an online intervention, supporting adults struggling with substance use. It provides psychoeducation and skills building exercises in CBT and compatible approaches. The intervention strategies contained within BFO are provided via a six-domain biopsychosocial model used in CBT. Each domain of the model corresponds to a module in the BFO program which contains psychoeducation and an 'action' strategy to facilitate behaviour change. Data captured at the baseline assessment is used by the program to provide feedback to the individual on their levels of functioning across the six domains. The program then guides the user to concentrate on intervention strategies for domains with the greatest level of impairment. All groups will receive 'clinical monitoring,' including biweekly study assessments during the acute treatment period and monthly assessments during the six month follow-up period. |
Interactive program utilizing cognitive behavioural therapy principles that guides users through its components and provides feedback, which facilitates behavior change (i.e., reduction in alcohol or substance use).
Other Names:
|
|
Experimental: Online Cognitive Behavioural Therapy Plus Individual Peer Support
BFO delivered with peer support will comprise BFO with at least weekly contact with a peer with lived experience. Peer support workers will receive training on how to facilitate participant engagement with and progress through the BFO program, as well as a weekly session plan. As part of this training, peer support workers will be given their own access code to use BFO and be encouraged to use the program. Session One constitutes an initial orienting to the program. Subsequent sessions review each information and action strategy in the BFO program, with a series of prompts to guide peer support of this content. All groups will receive 'clinical monitoring,' including biweekly study assessments during the acute treatment period and monthly assessments during the six month follow-up period. |
Interactive program utilizing cognitive behavioural therapy principles that guides users through its components and provides feedback, which facilitates behavior change (i.e., reduction in alcohol or substance use).
Other Names:
Weekly meetings with a trained peer support worker who guides participants through the BFO platform, reviews the platform's content with them, and supports them in the creation of an action strategy based on the platform's suggestions.
Other Names:
|
|
Active Comparator: Group Peer Support
The control condition will consist of group peer support facilitated by trained peers and offered through the Community Addictions Peer Support Association (CAPSA). The group meets weekly and will offer participants a space to share their experiences and receive support. All groups will receive 'clinical monitoring,' including biweekly study assessments during the acute treatment period and monthly assessments during the six month follow-up period. |
Meetings with a group of peers led by a trained peer support worker/volunteer which will offer the participants an opportunity to discuss their experiences in a supportive and open environment.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Timeline Follow-Back
Time Frame: 30 days
|
Frequency (days) of substance use over the past 30 days
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Qualitative Interview
Time Frame: 10 months
|
This interview will follow established principles of qualitative research and include questions specifically designed for this study.
This interview will have a two-pronged focus including (1) barriers and facilitators to the implementation of online CBT and (2) a complementary ethnographic focus on "health work" patients engage in to understand the impact of online CBT and explore ways to optimally deliver support during the care journey.
Thematic analysis of interview data will be undertaken to offer a summative description of how patients give meaning to their experience.
|
10 months
|
|
Program and Client Costs- Substance Abuse Treatment (PACC-SAT)
Time Frame: 7 days
|
Healthcare costs
|
7 days
|
|
Severity of Dependence Scale
Time Frame: 1 month
|
A self-report questionnaire assessing the severity of drug dependence.
The minimum possible score is 0 and the maximum is 15, with higher scores indicating more severe dependence.
|
1 month
|
|
Alcohol Use Disorder Identification Test
Time Frame: 1 month
|
Alcohol use and associated harms.
The minimum possible score is 0 and the maximum is 40, with higher scores indicating more harmful alcohol use.
|
1 month
|
|
Drug Use Disorders Identification Test
Time Frame: 1 month
|
Drug use and associated harms.
The minimum possible score is 0 and the maximum is 44, with higher scores indicating more harmful drug use.
|
1 month
|
|
Patient Health Questionaire-9
Time Frame: 14 Days
|
Depression symptom severity.
The minimum possible score is 0 and the maximum is 27, with higher scores indicating more severe depression.
|
14 Days
|
|
Generalized Anxiety Disorder-7
Time Frame: 14 days
|
Generalized anxiety symptom severity.
The minimum possible score is 0 and the maximum is 24, with higher scores indicating more severe anxiety.
|
14 days
|
|
World Health Organization Quality of Life Assessment
Time Frame: 4 weeks
|
Quality of life over four domains.
Subscale scores are calculated for 4 domains (physical health, psychological, social relationships and environment) and for "overall" and "general health" quality of life.
Subscale scores have a range of 0 to 100, with higher scores indicating greater quality of life.
|
4 weeks
|
|
Substance Use Calendar (SUC)
Time Frame: 14 days
|
This chart that will collect self-reports of alcohol and drug use and quantities of primary substance used.
|
14 days
|
|
Brief COPE Scale
Time Frame: Baseline, up to 8 weeks, and up to 6 months
|
Frequency of use of different coping strategies in response to stressors.
Each coping strategy is rated on a scale of 1 to 4, with higher scores indicating more use of the strategy.
|
Baseline, up to 8 weeks, and up to 6 months
|
|
Adult Hope Scale
Time Frame: Baseline, up to 8 weeks, and up to 6 months
|
Assessment of level of hope.
The minimum possible score is 12 and the maximum is 96, with higher scores indicating higher levels of hope.
|
Baseline, up to 8 weeks, and up to 6 months
|
|
Positive and Negative Affect Schedule - Expanded Form
Time Frame: 30 days
|
Positive and negative affect as well as additional specific affects.
The minimum score for each emotion is 1 and the highest possible score for each emotion is 5, with higher scores indicating more intensity of that emotion.
Composite scores are computed for general positive and general negative affect, with a minimum total score of 10 and a maximum total score of 50 for each type, with higher scores indicating higher presence of that type of affect.
Additional specific affect total scores are also computed with higher scores indicating more presence of the affect.
|
30 days
|
|
Contemplation Ladder
Time Frame: Baseline, up to 8 weeks, and up to 6 months
|
Assessment of participant perspectives about changing substance use.
The minimum score is 1 and the highest possible score is 10, with higher scores indicating more change in substance use.
|
Baseline, up to 8 weeks, and up to 6 months
|
|
Treatment Acceptability/Adherence Scale
Time Frame: Baseline, up to 8 weeks, and up to 6 months
|
Treatment acceptability and anticipated or actual adherence in response to a given treatment.
The minimum possible score is 10 and the maximum is 70, with higher scores indicating more acceptability or adherence to the treatment.
|
Baseline, up to 8 weeks, and up to 6 months
|
|
World Health Organization Disability Assessment Schedule 2.0
Time Frame: 30 days
|
Overall level of functioning.
The minimum possible score is 0 and the maximum is 100, with higher scores indicating more disability.
|
30 days
|
Collaborators and Investigators
Investigators
- Principal Investigator: Lena C. Quilty, PhD, Centre for Addiction and Mental Health
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 031/2020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Use Disorders
-
University of ArkansasNational Center for Advancing Translational Sciences (NCATS)RecruitingParenting | Substance Use Treatment | Perinatal Substance UseUnited States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingTobacco Use | Substance Use DisordersUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Substance Use Disorders | Cannabis Use | Alcohol Use, UnspecifiedUnited States
-
Wake Forest University Health SciencesNational Institute on Drug Abuse (NIDA)CompletedSubstance Use | Opioid Use | Drug Use | Substance MisuseUnited States
-
Woebot HealthNational Institute on Drug Abuse (NIDA); Stanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingTobacco Use Disorder | Substance Use Disorder (SUD)United States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)Active, not recruitingSubstance Use Disorder | Cocaine Use DisorderUnited States
-
Indiana UniversityNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use Disorders | Nicotine Use DisorderUnited States
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
Clinical Trials on Online Cognitive Behavioural Therapy
-
University of Southern DenmarkIrish Research Council; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaboratorsUnknown
-
Chinese University of Hong KongRecruitingMental Health Wellness 1 | Mental Well-being | Mental Health Issue | Precision Mental HealthHong Kong
-
University of British ColumbiaCompletedFemale Sexual DysfunctionCanada
-
McMaster UniversityActive, not recruitingPostpartum Depression | Postpartum AnxietyCanada
-
Our Lady's Hospice and Care ServicesSt Vincent's University Hospital, IrelandEnrolling by invitation
-
University of ZurichAmbulatorium für kognitive Verhaltenstherapie und Verhaltensmedizin - UZH; Lamprecht...Not yet recruitingPostpartum Depression | Major Depressive Disorder | Generalized Anxiety | Prenatal AnxietySwitzerland
-
Dublin City UniversityCompletedDepression | Self Concept | Body Fat Composition | Perceived Social SupportIreland
-
Lawson Health Research InstituteUniversity of Western Ontario, CanadaRecruiting
-
University of AberdeenCompleted